Pfizer Inc. (PFE): Safe And Steady Dividends

Conclusion

Pfizer is one of the largest global pharmaceutical companies in the world with numerous blockbuster therapeutics rounding out their diversified portfolio.

However, the company does face real challenges with generic competition to some of their blockbuster drugs. To combat these challenges, Pfizer is restocking the pipeline through internal investment and a couple recent major acquisitions.

Overall, Pfizer seems like a good company to consider for investors living off dividends in retirement. The company has a good balance sheet, enjoys a business model that performs well in all economic environments, generates plenty of free cash flow to cover the dividend, and offers a 3.6% dividend yield, which is nearly twice as high as the overall market’s yield.

Disclosure: None